Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome

NCT02019706 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

NIH

Sponsor class

Conditions

ACTH
Cushing's Syndrome

Interventions

RADIATION: DOTATATE PET-CT
RADIATION: F-DOPA PET CT
RADIATION: CT scan
DIAGNOSTIC_TEST: Routine MRI scan
DIAGNOSTIC_TEST: Gated MRI scan
DRUG: 68Ga-DOTATATE
DRUG: 18F-DOPA

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)